Annual Total Debt
$71.79 M
+$31.92 M+80.06%
December 31, 2023
Summary
- As of February 7, 2025, GALT annual total debt is $71.79 million, with the most recent change of +$31.92 million (+80.06%) on December 31, 2023.
- During the last 3 years, GALT annual total debt has risen by +$71.74 million (+163052.27%).
- GALT annual total debt is now at all-time high.
Performance
GALT Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$104.59 M
+$11.12 M+11.90%
September 30, 2024
Summary
- As of February 7, 2025, GALT quarterly total debt is $104.59 million, with the most recent change of +$11.12 million (+11.90%) on September 30, 2024.
- Over the past year, GALT quarterly total debt has increased by +$43.37 million (+70.84%).
- GALT quarterly total debt is now at all-time high.
Performance
GALT Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
GALT Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +80.1% | +70.8% |
| 3 y3 years | +10000.0% | +441.4% |
| 5 y5 years | +100.0% | +10000.0% |
GALT Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +147.1% | at high | +259.9% |
| 5 y | 5-year | at high | >+9999.0% | at high | >+9999.0% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Galectin Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $104.59 M(+11.9%) |
| Jun 2024 | - | $93.47 M(+13.3%) |
| Mar 2024 | - | $82.52 M(+14.9%) |
| Dec 2023 | $71.79 M(+80.1%) | $71.79 M(+17.3%) |
| Sep 2023 | - | $61.22 M(+1.3%) |
| Jun 2023 | - | $60.40 M(+20.7%) |
| Mar 2023 | - | $50.04 M(+25.5%) |
| Dec 2022 | $39.87 M(+37.2%) | $39.87 M(+33.6%) |
| Sep 2022 | - | $29.85 M(+0.8%) |
| Jun 2022 | - | $29.62 M(+1.1%) |
| Mar 2022 | - | $29.29 M(+0.8%) |
| Dec 2021 | $29.06 M(>+9900.0%) | $29.06 M(+50.4%) |
| Sep 2021 | - | $19.32 M(+99.7%) |
| Jun 2021 | - | $9.67 M(>+9900.0%) |
| Mar 2021 | - | $42.00 K(-4.5%) |
| Dec 2020 | $44.00 K(+12.8%) | $44.00 K(-29.0%) |
| Sep 2020 | - | $62.00 K(-13.9%) |
| Jun 2020 | - | $72.00 K(-11.1%) |
| Mar 2020 | - | $81.00 K(+107.7%) |
| Dec 2019 | $39.00 K(>+9900.0%) | $39.00 K(+5.4%) |
| Sep 2019 | - | $37.00 K(+2.8%) |
| Jun 2019 | - | $36.00 K(+5.9%) |
| Mar 2019 | - | $34.00 K(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(-100.0%) |
| Dec 2008 | $200.00 K(>+9900.0%) | $200.00 K(>+9900.0%) |
| Sep 2008 | - | $0.00(0.0%) |
| Jun 2008 | - | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) |
| Dec 2007 | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2007 | - | $275.00 K(-36.6%) |
| Jun 2007 | - | $434.00 K(>+9900.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2006 | - | $7.53 M(-34.2%) |
| Jun 2006 | - | $11.44 M(-22.9%) |
| Mar 2006 | - | $14.82 M(>+9900.0%) |
| Dec 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2005 | - | $0.00(0.0%) |
| Jun 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2004 | - | $0.00(0.0%) |
| Jun 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) |
| Dec 2003 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2003 | - | $0.00(0.0%) |
| Jun 2003 | - | $0.00(-100.0%) |
| Mar 2003 | - | $15.00 K(0.0%) |
| Dec 2002 | $15.00 K(-92.3%) | $15.00 K(-87.0%) |
| Sep 2002 | - | $115.00 K(0.0%) |
| Jun 2002 | - | $115.00 K(-41.0%) |
| Mar 2002 | - | $195.00 K(0.0%) |
| Dec 2001 | $195.00 K | $195.00 K(0.0%) |
| Sep 2001 | - | $195.00 K(-85.1%) |
| Jun 2001 | - | $1.31 M |
FAQ
- What is Galectin Therapeutics annual total debt?
- What is the all time high annual total debt for Galectin Therapeutics?
- What is Galectin Therapeutics annual total debt year-on-year change?
- What is Galectin Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Galectin Therapeutics?
- What is Galectin Therapeutics quarterly total debt year-on-year change?
What is Galectin Therapeutics annual total debt?
The current annual total debt of GALT is $71.79 M
What is the all time high annual total debt for Galectin Therapeutics?
Galectin Therapeutics all-time high annual total debt is $71.79 M
What is Galectin Therapeutics annual total debt year-on-year change?
Over the past year, GALT annual total debt has changed by +$31.92 M (+80.06%)
What is Galectin Therapeutics quarterly total debt?
The current quarterly total debt of GALT is $104.59 M
What is the all time high quarterly total debt for Galectin Therapeutics?
Galectin Therapeutics all-time high quarterly total debt is $104.59 M
What is Galectin Therapeutics quarterly total debt year-on-year change?
Over the past year, GALT quarterly total debt has changed by +$43.37 M (+70.84%)